Association of the YTHDF2 rs3738067 A>G variant with hepatoblastoma risk: a multicenter case-control study in Chinese children
Year: 2025
Type: article
Study design: Observational Study
Abstract: BACKGROUND: As a rare cancer, hepatoblastoma is the most prevalent malignant liver tumor in children, yet its underlying causes are poorly understood. YTHDF2, a canonical m⁶A reader, regulates mRNA stability and decay, and its dysregulation has been implicated in tumorigenesis across multiple malignancies. Whether YTHDF2 polymorphisms influence hepatoblastoma risk is unclear. This multicenter case-control study was therefore designed to analyze the YTHDF2 rs3738067 A > G variant in Chinese children. METHODS: We recruited 313 hepatoblastoma cases and 1446 controls from seven hospitals across China for this case-control study. The YTHDF2 rs3738067 A > G polymorphism was genotyped using the TaqMan PCR method. We assessed its association with hepatoblastoma risk using multivariate logistic regression to calculate adjusted odds ratios and 95% confidence intervals, controlling for age and sex. RESULTS: Comprehensive analyses of this multi-center Chinese pediatric cohort revealed that the YTHDF2 rs3738067 A > G polymorphism was not associated with hepatoblastoma risk in any analysis, including the overall population and all stratified subgroups. CONCLUSIONS: These findings suggest that this specific YTHDF2 variant may not be a key risk factor for hepatoblastoma in Chinese children. Future studies incorporating diverse ethnic populations and investigating other polymorphisms, alone or in combination, are warranted to confirm these findings and explore potential associations.
Source: BMC Cancer
Authors: Zhuo Wang, Jinhong Zhu, Wenli Zhang, Zhonghua Yang, Yong Li, Li Li, Suhong Li, Jiwen Cheng, Jiao Zhang, Jing He, Peng Yi
Institutions: Guangzhou Women and Children Medical Center, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Medical University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Sheng Jing Hospital, China Medical University, Hunan Children's Hospital, Kunming Children's Hospital, Shanxi Provincial Children's Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Zhengzhou University, First Affiliated Hospital of Zhengzhou University, Wenzhou Medical University, Quzhou City People's Hospital
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,390
Award: G8099378504
OpenAlex ID: W4417418030
